First domestically developed/manufactured oral cholera vaccine acquires WHO PQ
On the 12th, the International Vaccine Institute(IVI) and Eubiologics announced ‘Euvichol,’ an inactivated oral cholera vaccine manufactured by Eubiologics, has recently acquired the prequalification(PQ) by the World Health Organization(WHO).
Euvichol, a vaccine used twice orally, was developed ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.